Side effects by self-reported breast cancer patients who received chemotherapy after using the mobile application for tracking symptoms and symptom management. The quality of life of breast cancer patients who received chemotherapy after using the mobile application Symptom burden Management Breast cancer Chemotherapy Side effects Mobile application
Conditions
Interventions
Using a mobile application and standard care after receiving chemotherapy ,Providing standard care after receiving chemotherapy
a mobile application ,standard care only
Sponsors
Navamindradhiraj University Research Fund
Eligibility
Sex/Gender
All
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: (1) diagnosed with breast cancer stages 1-4, (2) aged 18 to 59 years, (3) receiving chemotherapy with a single regimen such as CMF (Cyclophosphamide, Methotrexate, Fluorouracil), AC (Doxorubicin, Cyclophosphamide), FAC (Fluorouracil, Doxorubicin, Cyclophosphamide), ACT (Doxorubicin, Cyclophosphamide, Paclitaxel), TC (Docetaxel, Cyclophosphamide), or targeted therapy, (4) owning a smartphone with an Android operating system, and (5) having a caregiver.
Exclusion criteria
Exclusion criteria: diagnosis of brain metastasis or inability to access the internet
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life After using ChemoPro Application at 21 EORTC QLQ-C30 | — |
Secondary
| Measure | Time frame |
|---|---|
| side effects experienced by cancer patients After using ChemoPro at 1, 3, 7, and 14 The NCI-PRO-CTCAE ITEMS-THAI-THAILAND version 1.0 ,Quality of Life After using ChemoPro Application at 21 EORTC QLQ-BR23 | — |
Countries
Thailand
Contacts
Public ContactDuangrat Kaveenuntachai
Kuakarun Faculty of Nursing, Navamindradhiraj University
Outcome results
None listed